Capula Management’s Verona Pharma VRNA Stock Holding History

Capula Management’s Portfolio VRNA Stock Details VRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-295,665	Closed	-$31.6M	–	937
2025 Q3	$31.6M	Buy	+295,665	New	+$30.9M	0.16%	66

Other funds holding VRNA

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Capula Management's VRNA Position: Q4 2025 in Review

Capula Management sold out of Verona Pharma (VRNA) in Q4 2025, closing a stake of 295,665 shares — an estimated $31.6M sold.

Capula Management first reported a position in VRNA in Q3 2025 and held it in 1 quarter. The position peaked at $31.6M in Q3 2025. 1 fund tracked by Wall St. Rank holds VRNA as of Q4 2025.

Capula Management reported no remaining Verona Pharma position as of Q4 2025 after selling out during the quarter.
Capula Management sold 295,665 Verona Pharma shares in Q4 2025, an estimated $31.6M.
Capula Management first reported a position in Verona Pharma in Q3 2025 and held it in 1 quarter.
Capula Management's Verona Pharma position peaked at $31.6M in Q3 2025.
1 fund tracked by Wall St. Rank held Verona Pharma as of Q4 2025.

Based on Capula Management's 13F filing for Q4 2025, filed 13 Feb 2026.